Tag: Novartis

Novartis

Novartis Works to Enhance Employee Experience

Originally published on novartis.com. Learning and Development In 2018 we crowdsourced ideas from associates on how to enhance the Novartis employee experience. One of the winning ideas was accessing more vocational training for all associates regardless of role, level or location and in the summer of 2019 that idea became…

Novartis

Novartis stands behind Zolgensma® for the treatment of children less than 2 years of age with spinal muscular atrophy

Today the FDA released a statement addressing data integrity issues with the Biologics License Application (BLA) for Zolgensma® (onasemnogene abeparvovec-xioi). First and foremost, we are fully confident in the safety, quality and efficacy of Zolgensma. The FDA supports the continued marketing and use of Zolgensma for patients with spinal muscular…

Novartis

Novartis: Three-Quarters of People Living with Axial Spondyloarthritis Struggle to Find a Job, IMAS Survey Shows

New European data from IMAS survey show that people living with axial spondyloarthritis (axSpA) suffer a delay in diagnosis of over 7 years, potentially leading to an increase in work-related issues[1] due to worsening disease burden The European results of the International Map of Axial Spondyloarthritis (IMAS) reveal that people…

Novartis

Novartis Announces New Leader of Pharmaceuticals Business Unit

Marie-France Tschudin, an experienced Novartis leader, appointed to President, Novartis Pharmaceuticals Novartis has announced that Marie-France Tschudin, currently President, Advanced Accelerator Applications (AAA), a Novartis company, has been appointed President, Novartis Pharmaceuticals. She will report to Vas Narasimhan, CEO Novartis, and will join the Executive Committee with immediate effect. Marie-France…

Novartis, Women in science

Novartis Women in Science: Sandrine Piret-Gérard

Sandrine Piret-Gérard, Vice President and Head of US Hematology at Novartis, reflects on what’s inspired her career in health care. Originally Published by Novartis. Growing up around doctors, pharmacists and specialty nurses, Sandrine Piret-Gérard knew she was destined to work in health care. Piret-Gérard joined Novartis in 2004 and today…

Novartis

Novartis Continues Transformation into a Leading Medicines Company with Completion of the Alcon Spin-off

Originally Published by Novartis Pharmaceuticals. Novartis positioned for sustained growth, including plans to improve Innovative Medicines core margins into mid-30s by 2022. Novartis completed the spin-off of the Alcon eye care devices business through a dividend-in-kind distribution to holders of Novartis shares and ADRs (American Depositary Receipts), with each holder…